Werkgroep Cardiologische centra Nederland English

THEMIS (Klaar)

A multinational, randomised, double-blind, placebo-controlled trial to evaluate the effect of ticagrelor 90mg twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus
Middel
ticagrelor
Populatie
diabetes mellitus
Fase
III
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov